Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap.
In This Week’s Edition, We Recap and Countdown the Top 10 Cannabis and Psychedelics Industry News Stories for the Week of February 15th – 21st, 2021.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view the full article.
Poised to Capitalize on the Massive New Market Opportunity, Creso Pharma Has Signed an Exclusive Distribution Deal to Bring the Company’s CBD Products Into Pakistan and the Philippines
Creso Pharma (OTC: COPHF) announced the signing of a new comprehensive distribution agreement with Route2 Pharm, a leading nutritional supplements company to bring Creso’s innovative Hemp-derived CBD products into the Asian markets of Pakistan and the Philippines. The deal will also see Creso look at other potential target markets, with an additional total addressable market of over 750 million people.
Psychedelics Are Going Mainstream – Not Only is the U.S. FDA Supportive of Research, But Dozens of Medical Studies Are Proving Such Treatments Could Be Helpful, Including Johns Hopkins Medicine and New York University
In research to date, Psilocybin has been found to help treat mental health issues, such as depression, anxiety, obsessive-compulsive disorder, and PTSD. LSD may be able to help patients with alcohol addiction and other mental disorders. MDMA-assisted therapy could help treat eating disorders, including anorexia and binge eating.
Following the Arizona Launch, Platinum Vape Products Will Be Available in 5 of America’s Top 10 Revenue Generating States, With Combined 2020 Sales of Over $7.6 Billion